Impact of age on retention in care and viral suppression

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 4, 2015, Pages 413-419

  Yehia, Baligh R ^a   Rebeiro, Peter ^b   Althoff, Keri N ^c   Agwu, Allison L ^c   Horberg, Michael A ^d   Samji, Hasina ^e   Napravnik, Sonia ^f   Mayer, Kenneth ^g   Tedaldi, Ellen ^h   Silverberg, Michael J ⁱ   Thorne, Jennifer E ^a   Burchell, Ann N ^j   Rourke, Sean B ^j   Rachlis, Anita ^j   Mayor, Angel ^k   Gill, Michael J ^l   Zinski, Anne ^m   Ohl, Michael ⁿ   Anastos, Kathryn ^o   Abraham, Alison G ^c   Kitahata, Mari M ^p   Moore, Richard D ^c   Gebo, Kelly A ^c   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d KAISER PERMANENTE   (United States)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g FENWAY INSTITUTE   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ DIVISION OF RESEARCH   (United States)

^j ONTARIO HIV TREATMENT NETWORK   (Canada)

^k Retrovirus Research Center Universidad Central del Caribeyamon   (Puerto Rico)

^l UNIVERSITY OF CALGARY   (Canada)

^m University of Alabama at Birmingham   (United States)

ⁿ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^o MONTEFIORE MEDICAL CENTER   (United States)

^p UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

age; engagement; HIV; retention in care; viral suppression

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; ASSESSMENT OF HUMANS; BLACK PERSON; CLINICAL OBSERVATION; CROSS-SECTIONAL STUDY; FEMALE; GROUPS BY AGE; HETEROSEXUAL TRANSMISSION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PRIORITY JOURNAL; RETENTION IN CARE; US DEPARTMENT OF HEALTH AND HUMAN SERVICES MEASURE; US NATIONAL HIV AIDS STRATEGY MEASURE; VIRAL SUPPRESSION; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; AGED; CANADA; HIV INFECTIONS; MEDICATION COMPLIANCE; UNITED STATES; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84924480393     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000489     Document Type: Article

References (53)

1. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618-1623
2. Fleishman JA, Yehia BR, Moore RD, et al. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249-259
3. Mugavero MJ. Improving engagement in HIV care: what can we do?. Top HIV Med. 2008;16:156-161
4. Horstmann E, Brown J, Islam F, et al. Retaining HIV-infected patients in care: where are we?. Where do we go from here?. Clin Infect Dis. 2010;50: 752-761
5. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23:41-49
6. Berg MB, Safren SA, Mimiaga MJ, et al. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Patient Care STDS. 2005;17:902-907
7. Giordano TP, White AC Jr, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003;32:399-405
8. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81-87
9. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248-256
10. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47:577-584
11. Yehia BR, Kangovi S, Frank I. Patients in transition: avoiding detours on the road to HIV treatment success. AIDS. 2013
12. Yehia BR, Fleishman JA, Moore RD, et al. Retention in care and health outcomes of transgender persons living with HIV. Clin Infect Dis. 2013
13. MugaveroMJ, Westfall AO, Zinski A, et al.Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61:574-580
14. Tripathi A, Youmans E, Gibson JJ, et al. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses. 2011;27:751-758
15. Yehia BR, French B, Fleishman JA, et al. Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr. 2013
16. Dombrowski JC, Kitahata MM, Van Rompaey SE, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013;63:299-306
17. Hanna DB, Buchacz K, Gebo KA, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013;56:1174-1182
18. Yehia BR, Fleishman JA, Metlay JP, et al. Sustained viral suppression in HIVinfected patients receiving antiretroviral therapy. JAMA. 2012;308:339-342
19. Cohen SM, Hu X, Sweeney P, et al. HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 U.S. jurisdictions. J Acquir Immune Defic Syndr. 2014
20. Robertson M, Laraque F, Mavronicolas H, et al. Linkage and retention in care and the time to HIV viral suppression and viral rebound-New York City. AIDS. 2014:1-8
21. Hall HI, Tang T, Westfall AO, et al. HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy. PLoS One. 2013;8:e84318
22. Torian LV, Xia Q, Wiewel EW. Retention in care and viral suppression among persons living with HIV/AIDS in New York city, 2006-2010. Am J Public Health. 2014;104:e24-29
23. Barclay TR, Hinkin CH, Castellon SA, et al. Age-Associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40-49
24. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIVinfected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(suppl 1):S19-S25
25. Ghidei L, Simone MJ, Salow MJ, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging. 2013;30:809-819
26. Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684-691
27. Holtzman C, Armon C, Tedaldi E, et al. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med. 2013;28:1302-1310
28. Greene M, Justice AC, Lampiris HW, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309: 1397-1405
29. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North american AIDS cohort collaboration on research and design (NAACCORD). Int J Epidemiol. 2007;36:294-301
30. Rebeiro P, Althoff KN, Buchacz K, et al. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013;62:356-362
31. Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. AIDS Res Hum Retroviruses. 2007;23:769-776
32. Yehia BR, Fleishman JA, Metlay JP, et al. Comparing different measures of retention in outpatient HIV care. AIDS. 2012;26:1131-1139
33. White House Office of National HIV/AIDS Policy. The national HIV/AIDS strategy of the United States. 2010
34. Forsyth AYV. Secretary sebelius approves indicators for monitoring HHS-funded HIV services. Office of HIV/AIDS and infectious disease policy, US Department of Health and Human Services 2012. Available at: http://blog.aids.gov/2012/08/secretary-sebelius-Approves-indicatorsfor-monitoring-hhs-funded-hiv-services.html. Accessed January 5, 2014
35. Giordano TP. How Should We Measure Retention in HIV Care?. 2012. Available at: http://www.medscape.com/viewarticle/768913. Accessed September 29, 2014
36. Crawford TN, Sanderson WT, Thornton A. A comparison study of methods for measuring retention in HIV medical care. AIDS Behav. 2013;17:3145-3151
37. Health Resources and Services Administration. HIV/AIDS Bureau performance measures. 2013. Available at: http://hab.hrsa.gov/.deliverhivaidscare/coremeasures.pdf
38. Centers for Disease Control and Prevention. Estimated HIV incidence among adults and adolescents in the United States, 2007-2010. HIV Surv Suppl Rep. 2012;17:4
39. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28:128-135
40. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156:817-833
41. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned?. AIDS Educ Prev. 2003;15:49-69
42. Vanable PA, Carey MP, Blair DC, et al. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav. 2006;10:473-482
43. Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 suppl 2):18640
44. Emlet CA. A comparison of HIV stigma and disclosure patterns between older and younger adults living with HIV/AIDS. AIDS Patient Care STDS. 2006;20:350-358
45. Dowshen N, Binns HJ, Garofalo R. Experiences of HIV-related stigma among young men who have sex with men. AIDS Patient Care STDS. 2009;23:371-376
46. Webel AR, Longenecker CT, Gripshover B, et al. Age, stress, and isolation in older adults living with HIV. AIDS. 2013
47. Grov C, Golub SA, Parsons JT, et al. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS. 2010;22:630-639
48. Swendeman D, Rotheram-Borus MJ, Comulada S, et al. Predictors of HIV-related stigma among young people living with HIV. Health Psychol. 2006;25:501-509
49. Crawford TN, Sanderson WT, Breheny P, et al. Impact of non-HIV related comorbidities on retention in HIV medical care: does retention improve over time?. AIDS Behav. 2014;18:617-624
50. Yehia BR, Schranz AJ, Momplaisir F, et al. Outcomes of HIV-infected patients receiving care at multiple clinics. AIDS Behav. 2013
51. Giordano TP, Visnegarwala F, White AC Jr, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS. 2005;17:773-783
52. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355
53. Ford MA, Spicer CM. Monitoring HIV Care in the United States: Indicators and Data Systems. Washington, DC: National Academies Press; 2012